-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
10x Genomics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2018 to Q2 2024.
- 10x Genomics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $818K, a 50.3% decline year-over-year.
- 10x Genomics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $6.56M, a 21% increase year-over-year.
- 10x Genomics, Inc. annual Income Tax Expense (Benefit) for 2023 was $6.34M, a 57.3% increase from 2022.
- 10x Genomics, Inc. annual Income Tax Expense (Benefit) for 2022 was $4.03M, a 10.6% decline from 2021.
- 10x Genomics, Inc. annual Income Tax Expense (Benefit) for 2021 was $4.51M, a 45.4% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)